AMN Healthcare Services (AMN) Stock Trades At A Discount Following Its 123% YTD Run

AMN Healthcare Services has surged 123.1% year to date, yet its valuation checks are split, with the intrinsic value estimate suggesting the stock trades at a discount while market multiples point in the opposite direction.

• The year to date gain of 123.1% has quickly repriced expectations, which raises the bar for any further upside to be supported by fundamentals.
• Future cash flow from healthcare staffing contracts can support the current share price if execution stays solid. However, any pressure on bill rates or utilization may weigh heavily on what investors are willing to pay.
• The broader valuation screen is a mixed picture rather than a clear bargain or obvious overpricing, with AMN Healthcare Services scoring a 4 out of 6 on value checks.

The issue now is whether AMN Healthcare Services is closer to its intrinsic value estimate, which implies a discount of about 22.1%, or to the richer story suggested by traditional earnings and revenue multiples.

Compare AMN Healthcare Services' sharp year to date re-rating with a curated list of other potential value opportunities screened as 49 high quality undervalued stocks.

Is AMN Healthcare Services a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model values AMN Healthcare Services by projecting the cash it can return to shareholders and then discounting those amounts back to today.

In this model, AMN Healthcare Services is treated as a business with currently strong but easing free cash generation, rather than a high growth story. Latest twelve month free cash flow is about $399.6 million, and the forecast path assumes lower annual free cash flow in coming years before settling into a more stable pattern. Feeding those projections into a 2 Stage Free Cash Flow to Equity model produces an estimated intrinsic value of about $43.33 per share.

Compared with the present share price, that intrinsic estimate implies the stock trades at roughly a 22.1% discount. The gap suggests the recent share price rebound has not fully closed what the DCF model views as remaining value supported by AMN Healthcare Services' cash flows.

On this cash flow view, AMN Healthcare Services appears undervalued relative to its DCF-based intrinsic value estimate.

Our Discounted Cash Flow (DCF) analysis suggests AMN Healthcare Services is undervalued by 22.1%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for AMN Healthcare Services.

Is AMN Healthcare Services Getting Expensive on Earnings?

The P/E ratio fits AMN Healthcare Services well because earnings still sit at the center of how investors think about this staffing specialist. On this yardstick, the stock trades on about 12.5x earnings, which is well below the broader Healthcare sector average of roughly 25.1x and far under the peer group at about 40.2x.

A more tailored model that blends AMN Healthcare Services' growth profile, margins, size, and risk points to a fair P/E closer to 2.9x. The gap between this figure and the actual 12.5x suggests the framework flags the shares as overvalued on this metric, even though the raw comparison with industry and peer multiples looks cheap at first glance.

On the preferred earnings multiple, AMN Healthcare Services screens as overvalued despite trading at a discount to typical Healthcare P/E levels.

See what the numbers say about this price — find out in our valuation breakdown.

The AMN Healthcare Services Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where AMN Healthcare Services' valuation puzzle leaves off by spelling out which assumptions on growth, margins, and earnings would need to hold for the shares to be worth materially more or less than today’s price on the Community page. Each Narrative treats fair value as a specific thesis about AMN Healthcare Services' business that you can watch over time rather than a single frozen snapshot.

AMN Healthcare Services pulls in sharply different community views, with one camp leaning into structural demand and tech, and the other focused on fragile staffing trends and pricing pressure.

Bull case: roughly fairly valued

"AMN's continued rollout of technology-driven solutions, including AI-enabled talent platforms, workforce automation, and the expanding Passport app, is producing operational efficiencies and greater user engagement. These developments are likely to improve net margins and reduce SG&A as a percentage of revenue over time…"

Read the full Bull Case to see why AMN Healthcare Services could be undervalued

Bear case: 27% overvalued

"Persistent volume pressure in Travel Nurse and Allied segments, with volume in Nurse and Allied down 16% year-over-year and key sub-segments such as Travel Nurse revenue down 25%, suggests demand normalization post-pandemic. This may limit revenue rebound even as the company invests in operational efficiencies and innovation…"

Read the full Bear Case to see why AMN Healthcare Services could be overvalued

Do you think there's more to the story for AMN Healthcare Services? Head over to our Community to see what others are saying!

The Bottom Line

AMN Healthcare Services looks undervalued on a Discounted Cash Flow (DCF) view, which focuses on the cash the business is expected to generate relative to today's price. Market multiples tell a different story and flag the stock as overvalued, largely because the tailored P/E framework is penalising the earnings profile more heavily than simple sector comparisons. That split comes from two different lenses: intrinsic value leaning on cash flow timing and investment needs, and the multiple view leaning on how much growth and pricing power investors are willing to underwrite. The real swing factor now is whether margins and bill rates hold up enough to keep cash generation resilient rather than sliding into a value trap.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com